| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | MA0-1 | Growth condition:Attached | time (h):0 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MA0-2 | Growth condition:Attached | time (h):0 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MA0-3 | Growth condition:Attached | time (h):0 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MA610-24-1 | Growth condition:Attached | time (h):24 | treatment:10µM 68c091 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MA610-24-2 | Growth condition:Attached | time (h):24 | treatment:10µM 68c091 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MA610-24-3 | Growth condition:Attached | time (h):24 | treatment:10µM 68c091 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAA10-24-1 | Growth condition:Attached | time (h):24 | treatment:10µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAA10-24-2 | Growth condition:Attached | time (h):24 | treatment:10µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAA10-24-3 | Growth condition:Attached | time (h):24 | treatment:10µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAA1-24-1 | Growth condition:Attached | time (h):24 | treatment:1µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAA1-24-2 | Growth condition:Attached | time (h):24 | treatment:1µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAA1-24-3 | Growth condition:Attached | time (h):24 | treatment:1µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAD-24-1 | Growth condition:Attached | time (h):24 | treatment:DMSO | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAD-24-2 | Growth condition:Attached | time (h):24 | treatment:DMSO | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAD-24-3 | Growth condition:Attached | time (h):24 | treatment:DMSO | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAT-24-1 | Growth condition:Attached | time (h):24 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAT-24-2 | Growth condition:Attached | time (h):24 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAT-24-3 | Growth condition:Attached | time (h):24 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAV-24-1 | Growth condition:Attached | time (h):24 | treatment:Vehicle | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAV-24-2 | Growth condition:Attached | time (h):24 | treatment:Vehicle | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAV-24-3 | Growth condition:Attached | time (h):24 | treatment:Vehicle | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MA610-48-1 | Growth condition:Attached | time (h):48 | treatment:10µM 68c091 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MA610-48-2 | Growth condition:Attached | time (h):48 | treatment:10µM 68c091 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MA610-48-3 | Growth condition:Attached | time (h):48 | treatment:10µM 68c091 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAA10-48-1 | Growth condition:Attached | time (h):48 | treatment:10µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAA10-48-2 | Growth condition:Attached | time (h):48 | treatment:10µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAA10-48-3 | Growth condition:Attached | time (h):48 | treatment:10µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAA1-48-1 | Growth condition:Attached | time (h):48 | treatment:1µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAA1-48-2 | Growth condition:Attached | time (h):48 | treatment:1µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAA1-48-3 | Growth condition:Attached | time (h):48 | treatment:1µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAD-48-1 | Growth condition:Attached | time (h):48 | treatment:DMSO | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAD-48-2 | Growth condition:Attached | time (h):48 | treatment:DMSO | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAD-48-3 | Growth condition:Attached | time (h):48 | treatment:DMSO | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAT-48-1 | Growth condition:Attached | time (h):48 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAT-48-2 | Growth condition:Attached | time (h):48 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAT-48-3 | Growth condition:Attached | time (h):48 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MA48-1 | Growth condition:Attached | time (h):48 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MA48-2 | Growth condition:Attached | time (h):48 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MA48-3 | Growth condition:Attached | time (h):48 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAV-48-1 | Growth condition:Attached | time (h):48 | treatment:Vehicle | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAV-48-2 | Growth condition:Attached | time (h):48 | treatment:Vehicle | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MAV-48-3 | Growth condition:Attached | time (h):48 | treatment:Vehicle | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MA72-1 | Growth condition:Attached | time (h):72 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MA72-2 | Growth condition:Attached | time (h):72 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MA72-3 | Growth condition:Attached | time (h):72 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MS0-1 | Growth condition:Suspension | time (h):0 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MS0-2 | Growth condition:Suspension | time (h):0 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MS0-3 | Growth condition:Suspension | time (h):0 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MS610-24-1 | Growth condition:Suspension | time (h):24 | treatment:10µM 68c091 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MS610-24-2 | Growth condition:Suspension | time (h):24 | treatment:10µM 68c091 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MS610-24-3 | Growth condition:Suspension | time (h):24 | treatment:10µM 68c091 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MSA10-24-1 | Growth condition:Suspension | time (h):24 | treatment:10µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MSA10-24-2 | Growth condition:Suspension | time (h):24 | treatment:10µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MSA10-24-3 | Growth condition:Suspension | time (h):24 | treatment:10µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MSA1-24-1 | Growth condition:Suspension | time (h):24 | treatment:1µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MSA1-24-2 | Growth condition:Suspension | time (h):24 | treatment:1µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MSA1-24-3 | Growth condition:Suspension | time (h):24 | treatment:1µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MSD-24-1 | Growth condition:Suspension | time (h):24 | treatment:DMSO | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MSD-24-2 | Growth condition:Suspension | time (h):24 | treatment:DMSO | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MSD-24-3 | Growth condition:Suspension | time (h):24 | treatment:DMSO | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MST-24-1 | Growth condition:Suspension | time (h):24 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MST-24-2 | Growth condition:Suspension | time (h):24 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MST-24-3 | Growth condition:Suspension | time (h):24 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MSV-24-1 | Growth condition:Suspension | time (h):24 | treatment:Vehicle | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MSV-24-2 | Growth condition:Suspension | time (h):24 | treatment:Vehicle | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MSV-24-3 | Growth condition:Suspension | time (h):24 | treatment:Vehicle | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MS610-48-1 | Growth condition:Suspension | time (h):48 | treatment:10µM 68c091 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MS610-48-2 | Growth condition:Suspension | time (h):48 | treatment:10µM 68c091 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MS610-48-3 | Growth condition:Suspension | time (h):48 | treatment:10µM 68c091 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MSA10-48-1 | Growth condition:Suspension | time (h):48 | treatment:10µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MSA10-48-2 | Growth condition:Suspension | time (h):48 | treatment:10µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MSA10-48-3 | Growth condition:Suspension | time (h):48 | treatment:10µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MSA1-48-1 | Growth condition:Suspension | time (h):48 | treatment:1µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MSA1-48-2 | Growth condition:Suspension | time (h):48 | treatment:1µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MSA1-48-3 | Growth condition:Suspension | time (h):48 | treatment:1µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MSD-48-1 | Growth condition:Suspension | time (h):48 | treatment:DMSO | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MSD-48-2 | Growth condition:Suspension | time (h):48 | treatment:DMSO | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MSD-48-3 | Growth condition:Suspension | time (h):48 | treatment:DMSO | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MST-48-1 | Growth condition:Suspension | time (h):48 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MST-48-2 | Growth condition:Suspension | time (h):48 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MST-48-3 | Growth condition:Suspension | time (h):48 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MS48-1 | Growth condition:Suspension | time (h):48 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MS48-2 | Growth condition:Suspension | time (h):48 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MS48-3 | Growth condition:Suspension | time (h):48 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MSV-48-1 | Growth condition:Suspension | time (h):48 | treatment:Vehicle | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MSV-48-2 | Growth condition:Suspension | time (h):48 | treatment:Vehicle | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MSV-48-3 | Growth condition:Suspension | time (h):48 | treatment:Vehicle | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MS72-1 | Growth condition:Suspension | time (h):72 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MS72-2 | Growth condition:Suspension | time (h):72 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase NEGATIVE ION MODE | MS72-3 | Growth condition:Suspension | time (h):72 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MA0-1 | Growth condition:Attached | time (h):0 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MA0-2 | Growth condition:Attached | time (h):0 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MA0-3 | Growth condition:Attached | time (h):0 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MA610-24-1 | Growth condition:Attached | time (h):24 | treatment:10µM 68c091 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MA610-24-2 | Growth condition:Attached | time (h):24 | treatment:10µM 68c091 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MA610-24-3 | Growth condition:Attached | time (h):24 | treatment:10µM 68c091 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAA10-24-1 | Growth condition:Attached | time (h):24 | treatment:10µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAA10-24-2 | Growth condition:Attached | time (h):24 | treatment:10µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAA10-24-3 | Growth condition:Attached | time (h):24 | treatment:10µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAA1-24-1 | Growth condition:Attached | time (h):24 | treatment:1µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAA1-24-2 | Growth condition:Attached | time (h):24 | treatment:1µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAA1-24-3 | Growth condition:Attached | time (h):24 | treatment:1µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAD-24-1 | Growth condition:Attached | time (h):24 | treatment:DMSO | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAD-24-2 | Growth condition:Attached | time (h):24 | treatment:DMSO | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAD-24-3 | Growth condition:Attached | time (h):24 | treatment:DMSO | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAT-24-1 | Growth condition:Attached | time (h):24 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAT-24-2 | Growth condition:Attached | time (h):24 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAT-24-3 | Growth condition:Attached | time (h):24 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAV-24-1 | Growth condition:Attached | time (h):24 | treatment:Vehicle | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAV-24-2 | Growth condition:Attached | time (h):24 | treatment:Vehicle | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAV-24-3 | Growth condition:Attached | time (h):24 | treatment:Vehicle | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MA610-48-1 | Growth condition:Attached | time (h):48 | treatment:10µM 68c091 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MA610-48-2 | Growth condition:Attached | time (h):48 | treatment:10µM 68c091 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MA610-48-3 | Growth condition:Attached | time (h):48 | treatment:10µM 68c091 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAA10-48-1 | Growth condition:Attached | time (h):48 | treatment:10µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAA10-48-2 | Growth condition:Attached | time (h):48 | treatment:10µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAA10-48-3 | Growth condition:Attached | time (h):48 | treatment:10µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAA1-48-1 | Growth condition:Attached | time (h):48 | treatment:1µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAA1-48-2 | Growth condition:Attached | time (h):48 | treatment:1µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAA1-48-3 | Growth condition:Attached | time (h):48 | treatment:1µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAD-48-1 | Growth condition:Attached | time (h):48 | treatment:DMSO | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAD-48-2 | Growth condition:Attached | time (h):48 | treatment:DMSO | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAD-48-3 | Growth condition:Attached | time (h):48 | treatment:DMSO | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAT-48-1 | Growth condition:Attached | time (h):48 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAT-48-2 | Growth condition:Attached | time (h):48 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAT-48-3 | Growth condition:Attached | time (h):48 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MA48-1 | Growth condition:Attached | time (h):48 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MA48-2 | Growth condition:Attached | time (h):48 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MA48-3 | Growth condition:Attached | time (h):48 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAV-48-1 | Growth condition:Attached | time (h):48 | treatment:Vehicle | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAV-48-2 | Growth condition:Attached | time (h):48 | treatment:Vehicle | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MAV-48-3 | Growth condition:Attached | time (h):48 | treatment:Vehicle | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MA72-1 | Growth condition:Attached | time (h):72 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MA72-2 | Growth condition:Attached | time (h):72 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MA72-3 | Growth condition:Attached | time (h):72 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MS0-1 | Growth condition:Suspension | time (h):0 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MS0-2 | Growth condition:Suspension | time (h):0 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MS0-3 | Growth condition:Suspension | time (h):0 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MS610-24-1 | Growth condition:Suspension | time (h):24 | treatment:10µM 68c091 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MS610-24-2 | Growth condition:Suspension | time (h):24 | treatment:10µM 68c091 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MS610-24-3 | Growth condition:Suspension | time (h):24 | treatment:10µM 68c091 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MSA10-24-1 | Growth condition:Suspension | time (h):24 | treatment:10µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MSA10-24-2 | Growth condition:Suspension | time (h):24 | treatment:10µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MSA10-24-3 | Growth condition:Suspension | time (h):24 | treatment:10µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MSA1-24-1 | Growth condition:Suspension | time (h):24 | treatment:1µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MSA1-24-2 | Growth condition:Suspension | time (h):24 | treatment:1µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MSA1-24-3 | Growth condition:Suspension | time (h):24 | treatment:1µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MSD-24-1 | Growth condition:Suspension | time (h):24 | treatment:DMSO | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MSD-24-2 | Growth condition:Suspension | time (h):24 | treatment:DMSO | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MSD-24-3 | Growth condition:Suspension | time (h):24 | treatment:DMSO | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MST-24-1 | Growth condition:Suspension | time (h):24 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MST-24-2 | Growth condition:Suspension | time (h):24 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MST-24-3 | Growth condition:Suspension | time (h):24 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MSV-24-1 | Growth condition:Suspension | time (h):24 | treatment:Vehicle | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MSV-24-2 | Growth condition:Suspension | time (h):24 | treatment:Vehicle | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MSV-24-3 | Growth condition:Suspension | time (h):24 | treatment:Vehicle | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MS610-48-1 | Growth condition:Suspension | time (h):48 | treatment:10µM 68c091 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MS610-48-2 | Growth condition:Suspension | time (h):48 | treatment:10µM 68c091 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MS610-48-3 | Growth condition:Suspension | time (h):48 | treatment:10µM 68c091 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MSA10-48-1 | Growth condition:Suspension | time (h):48 | treatment:10µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MSA10-48-2 | Growth condition:Suspension | time (h):48 | treatment:10µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MSA10-48-3 | Growth condition:Suspension | time (h):48 | treatment:10µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MSA1-48-1 | Growth condition:Suspension | time (h):48 | treatment:1µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MSA1-48-2 | Growth condition:Suspension | time (h):48 | treatment:1µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MSA1-48-3 | Growth condition:Suspension | time (h):48 | treatment:1µM AT0174 | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MSD-48-1 | Growth condition:Suspension | time (h):48 | treatment:DMSO | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MSD-48-2 | Growth condition:Suspension | time (h):48 | treatment:DMSO | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MSD-48-3 | Growth condition:Suspension | time (h):48 | treatment:DMSO | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MST-48-1 | Growth condition:Suspension | time (h):48 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MST-48-2 | Growth condition:Suspension | time (h):48 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MST-48-3 | Growth condition:Suspension | time (h):48 | treatment:NFkB cocktail 10 ng/ml IL1b + 10 ng/ml TNFa | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MS48-1 | Growth condition:Suspension | time (h):48 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MS48-2 | Growth condition:Suspension | time (h):48 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MS48-3 | Growth condition:Suspension | time (h):48 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MSV-48-1 | Growth condition:Suspension | time (h):48 | treatment:Vehicle | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MSV-48-2 | Growth condition:Suspension | time (h):48 | treatment:Vehicle | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MSV-48-3 | Growth condition:Suspension | time (h):48 | treatment:Vehicle | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MS72-1 | Growth condition:Suspension | time (h):72 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MS72-2 | Growth condition:Suspension | time (h):72 | treatment:none | Sample source:Breast cancer cells | peak area |
| Reversed phase POSITIVE ION MODE | MS72-3 | Growth condition:Suspension | time (h):72 | treatment:none | Sample source:Breast cancer cells | peak area |
Return to study ST003484 main page
Download data matrix(Metabolism of TNBC cell line MDA-MB-453 is altered by cytokines, TDO2 inhibition, or suspension growth conditions - cellular steady state metabolome and in vitro tracing with 13C11 tryptophan Reversed phase NEGATIVE ION MODE)
Download data matrix(Metabolism of TNBC cell line MDA-MB-453 is altered by cytokines, TDO2 inhibition, or suspension growth conditions - cellular steady state metabolome and in vitro tracing with 13C11 tryptophan Reversed phase POSITIVE ION MODE)
- Metabolomics Workbench
|